06.21.23
Gnosis by Lesaffre, a global supplier of fermentation-derived ingredients, has announced a number of changes that will improve its services and customer experience, highlight innovation and product development, and uphold corporate social responsibility.
“The customer is at the center of everything we do. We are here to guide them through bringing the best products to market, offering clinically validated ingredients that meet their specific needs. Our highest priority is to ensure that we take the burden off their shoulders while providing a transparent experience,” says Philippe Caillat, global marketing director.
Product Innovation
Gnosis has launched a phages-based ingredient line to elevate its portfolio of digestion and gut health ingredients. Phages, or bacteriophages, are viruses that can only survive and replicate within bacterial cells, and are emerging as a way to potentially enhance probiotics’ benefits. Phages may be suitable for dietary supplements, functional foods, and functional beverages in order to improve a products’ effect on the microbiome.
The company is also offering its Red Star nutritional yeast to food service in the U.S., with three-ounce jars which can be placed on tables in restaurants, as well as six- and 10-pound buckets for use in kitchens by chefs. The company also launched a Red Star Yeast website which features improved navigation and recipes.
Gnosis also launched L. rhamnosus GG 350, a version of its LifeinU product which meets the market-standard specification of 350.109 CFU/g, while using proprietary production processes to enhance stability.
Services
Gnosis introduced a new brand identity for its vitamin K2 ingredient, MenaQ7 Vitamin K2 as MK-7, which highlights clinical evidence supporting its role in bone and heart health along with new health indications and applications.
The company has also launched a new website, with additional content and resources such as e-books, white papers, videos, and infographics for an improved digital experience.
Corporate Responsibility
Gnosis added the role of Corporate Social Responsibility (CSR) manager in February this year in order to explore new initiatives and coordinate the company’s sustainability strategies.
These include annual carbon emission and water consumption reductions, improvements in the social impact of a supply chain, and joint action with community non-governmental organizations to impact wellbeing.
“These advancements have been in process for some time, with our team diligently working to ensure seamless transitions and purpose for our changes,” said Caillat. “We recognize that we still have more to bring to the market, including a rebranding of our Extrafolate-S in June. With our unwavering commitment to innovation and sustainability, we are excited to embark on this journey as an even stronger and more reliable partner for our customers.”
“The customer is at the center of everything we do. We are here to guide them through bringing the best products to market, offering clinically validated ingredients that meet their specific needs. Our highest priority is to ensure that we take the burden off their shoulders while providing a transparent experience,” says Philippe Caillat, global marketing director.
Product Innovation
Gnosis has launched a phages-based ingredient line to elevate its portfolio of digestion and gut health ingredients. Phages, or bacteriophages, are viruses that can only survive and replicate within bacterial cells, and are emerging as a way to potentially enhance probiotics’ benefits. Phages may be suitable for dietary supplements, functional foods, and functional beverages in order to improve a products’ effect on the microbiome.
The company is also offering its Red Star nutritional yeast to food service in the U.S., with three-ounce jars which can be placed on tables in restaurants, as well as six- and 10-pound buckets for use in kitchens by chefs. The company also launched a Red Star Yeast website which features improved navigation and recipes.
Gnosis also launched L. rhamnosus GG 350, a version of its LifeinU product which meets the market-standard specification of 350.109 CFU/g, while using proprietary production processes to enhance stability.
Services
Gnosis introduced a new brand identity for its vitamin K2 ingredient, MenaQ7 Vitamin K2 as MK-7, which highlights clinical evidence supporting its role in bone and heart health along with new health indications and applications.
The company has also launched a new website, with additional content and resources such as e-books, white papers, videos, and infographics for an improved digital experience.
Corporate Responsibility
Gnosis added the role of Corporate Social Responsibility (CSR) manager in February this year in order to explore new initiatives and coordinate the company’s sustainability strategies.
These include annual carbon emission and water consumption reductions, improvements in the social impact of a supply chain, and joint action with community non-governmental organizations to impact wellbeing.
“These advancements have been in process for some time, with our team diligently working to ensure seamless transitions and purpose for our changes,” said Caillat. “We recognize that we still have more to bring to the market, including a rebranding of our Extrafolate-S in June. With our unwavering commitment to innovation and sustainability, we are excited to embark on this journey as an even stronger and more reliable partner for our customers.”
